Madrigal Pharmaceuticals (MDGL) is up 12.4%, or $38.58 to $349.72.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDGL:
- Madrigal patent for Rezdiffra ‘significant win,’ says Piper Sandler
- Madrigal Pharmaceuticals receives notice of allowance for Rezdiffra patent
- Short Report: Rocket Companies short interest at record high
- Madrigal Pharmaceuticals: Positive CHMP Opinion and Phase 3 Success Drive Buy Rating
- Madrigal Pharmaceuticals Holds 2025 Annual Stockholders Meeting